NYSE
Bausch Health Companies Inc. (BHC)
♥ 614 Thanks from members
Bausch Health Companies Inc. (BHC) demonstrated robust Q2 2026 performance with strong revenue growth, raised full-year guidance, and significant margin expansion, though persistent long-term debt and interest burdens continue to drive deep analyst skepticism and market volatility.